Asian Growth Companies Insiders Are Betting On
As geopolitical tensions and trade-related concerns continue to shape global markets, Asian stocks have experienced mixed outcomes, with China's benchmark indices slightly declining amidst deflationary pressures and Japan's market showing varied returns. In this environment, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.
Name
Insider Ownership
Earnings Growth
Vuno (KOSDAQ:A338220)
15.6%
109.8%
Techwing (KOSDAQ:A089030)
18.8%
68%
Suzhou Sunmun Technology (SZSE:300522)
35.4%
77.7%
Sineng ElectricLtd (SZSE:300827)
36%
26.9%
Shanghai Huace Navigation Technology (SZSE:300627)
24.3%
23.5%
Samyang Foods (KOSE:A003230)
11.7%
24.3%
Nanya New Material TechnologyLtd (SHSE:688519)
11%
63.3%
M31 Technology (TPEX:6643)
30.8%
63.4%
Laopu Gold (SEHK:6181)
35.5%
40.3%
Fulin Precision (SZSE:300432)
13.6%
43%
Click here to see the full list of 611 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: China Ruyi Holdings Limited is an investment holding company involved in content production and online streaming across Mainland China, Hong Kong, Europe, and internationally, with a market cap of HK$33.99 billion.
Operations: The company's revenue is primarily derived from its online streaming and online gaming businesses, which account for CN¥3.51 billion, followed by its content production business generating CN¥127.04 million.
Insider Ownership: 16.9%
Revenue Growth Forecast: 27.4% p.a.
China Ruyi Holdings is poised for significant growth, with revenue expected to increase by 27.4% annually, outpacing the Hong Kong market. Earnings are projected to grow at 87.88% per year, with profitability anticipated within three years. However, return on equity is forecasted to remain low at 10.7%. Despite recent shareholder dilution and a net loss due to non-operating items in fiscal 2024, insider ownership remains substantial without notable trading activity in the past three months.
Delve into the full analysis future growth report here for a deeper understanding of China Ruyi Holdings.
Our expertly prepared valuation report China Ruyi Holdings implies its share price may be too high.
Simply Wall St Growth Rating: ★★★★★★
Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally, with a market cap of HK$88.73 billion.
Operations: The company generates revenue of CN¥2.12 billion from its activities in the research, development, production, and sale of biopharmaceutical products.
Insider Ownership: 18.9%
Revenue Growth Forecast: 29.7% p.a.
Akeso is positioned for robust growth with revenue forecasted to rise by 29.7% annually, surpassing the Hong Kong market's average. The company is expected to achieve profitability within three years, with earnings projected to grow at 58.28% per year and a high return on equity of 21.7%. Recent approvals of innovative therapies like cadonilimab and ivonescimab enhance its oncology portfolio, although recent financials show a net loss due to decreased revenue from CNY 4.53 billion to CNY 2.12 billion.
Dive into the specifics of Akeso here with our thorough growth forecast report.
Our valuation report here indicates Akeso may be overvalued.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Caliway Biopharmaceuticals Co., Ltd. develops drugs for aesthetic medicine and chronic inflammation, with a market cap of NT$155.38 billion.
Operations: Caliway Biopharmaceuticals Co., Ltd., along with its subsidiaries, focuses on developing pharmaceuticals targeting aesthetic medicine and chronic inflammation.
Insider Ownership: 24.3%
Revenue Growth Forecast: 81.1% p.a.
Caliway Biopharmaceuticals is poised for significant growth, with revenue expected to increase by over 81% annually, outpacing the Taiwan market. The company is on track to achieve profitability in three years. Recent regulatory milestones include FDA support for its innovative drug CBL-514, targeting measurable fat reduction. Despite a first-quarter net loss of NT$175.57 million, these developments provide a solid foundation for future growth and strategic advancement in biopharmaceuticals.
Take a closer look at Caliway Biopharmaceuticals' potential here in our earnings growth report.
The analysis detailed in our Caliway Biopharmaceuticals valuation report hints at an inflated share price compared to its estimated value.
Access the full spectrum of 611 Fast Growing Asian Companies With High Insider Ownership by clicking on this link.
Curious About Other Options? Uncover the next big thing with financially sound penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include SEHK:136 SEHK:9926 and TWSE:6919.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
1 Bank Stock to Target This Week and 2 to Approach with Caution
Banks serve as the backbone of the economy, facilitating lending, deposits, and financial services that keep businesses and consumers moving forward. But concerns about loan losses and tightening regulations have tempered enthusiasm, and over the past six months, the banking industry has pulled back by 6.9%. This drop was disappointing since the S&P 500 stood firm. Despite the lackluster result, a few diamonds in the rough can produce earnings growth no matter what, and we started StockStory to help you find them. With that said, here is one resilient bank stock at the top of our wish list and two we're passing on. Market Cap: $1.15 billion With roots dating back to 1910 and a name that evokes the historic "dime savings banks" of America's past, Dime Community Bancshares (NASDAQ:DCOM) is a New York-based bank holding company that provides commercial banking and financial services to businesses and consumers throughout Greater Long Island. Why Does DCOM Worry Us? Sales tumbled by 10.2% annually over the last two years, showing market trends are working against its favor during this cycle 51.7 basis point (100 basis points = 1 percentage point) decline in its net interest margin over the last two years reflects the company's willingness to accept lower yields to defend its market position Sales were less profitable over the last two years as its earnings per share fell by 35% annually, worse than its revenue declines At $26.49 per share, Dime Community Bancshares trades at 0.8x forward P/B. Check out our free in-depth research report to learn more about why DCOM doesn't pass our bar. Market Cap: $11.58 billion Operating as a real estate investment trust since 1996 with a focus on generating income from interest rate spreads, Annaly Capital Management (NYSE:NLY) is a diversified capital manager that invests in agency mortgage-backed securities, residential mortgage loans, and mortgage servicing rights. Why Should You Dump NLY? Inferior net interest margin of 0.1% means it must compensate for lower profitability through increased loan originations Earnings per share fell by 5.7% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable Annual tangible book value per share declines of 8.5% for the past five years show its capital management struggled during this cycle Annaly Capital Management's stock price of $19.19 implies a valuation ratio of 1x forward P/B. Read our free research report to see why you should think twice about including NLY in your portfolio, it's free. Market Cap: $5.64 billion With roots dating back to 1885 and a strategic focus on middle-market commercial lending, Cadence Bancorporation (NYSE:CADE) is a bank holding company that provides commercial banking, retail banking, and wealth management services to middle-market businesses and individuals. Why Do We Like CADE? Impressive 20% annual net interest income growth over the last four years indicates it's winning market share this cycle Earnings per share have outperformed the peer group average over the last two years, increasing by -2.4% annually Annual tangible book value per share growth of 22% over the past two years was outstanding, reflecting strong capital accumulation this cycle Cadence Bank is trading at $30.28 per share, or 1x forward P/B. Is now the right time to buy? Find out in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
2 Mooning Stocks to Keep an Eye On and 1 to Keep Off Your Radar
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance. But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. Keeping that in mind, here are two stocks with the fundamentals to back up their performance and one not so much. One-Month Return: +4.3% Founded in 2010 by Harvard Business School student Bom Kim, Coupang (NYSE:CPNG) is an e-commerce giant often referred to as the "Amazon of South Korea". Why Is CPNG Not Exciting? Gross margin of 28% reflects its high servicing costs Low free cash flow margin of 4.4% for the last two years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders At $28.63 per share, Coupang trades at 29.5x forward EV/EBITDA. If you're considering CPNG for your portfolio, see our FREE research report to learn more. One-Month Return: +5.8% Founded in 2013 by three French engineers who spent decades working for Oracle, Snowflake (NYSE:SNOW) provides a data warehouse-as-a-service in the cloud that allows companies to store large amounts of data and analyze it in real time. Why Should SNOW Be on Your Watchlist? Average billings growth of 26.5% over the last year enhances its liquidity and shows there is steady demand for its products Net revenue retention rate of 126% demonstrates its ability to expand within existing accounts through upsells and cross-sells Notable projected revenue growth of 24.4% for the next 12 months hints at market share gains Snowflake's stock price of $211.72 implies a valuation ratio of 14.8x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it's free. One-Month Return: +0.7% While the company is not a domain registrar and does not directly sell domain names to end users, Verisign (NASDAQ:VRSN) operates and maintains the infrastructure to support domain names such as .com and .net. Why Is VRSN on Our Radar? Average billings growth of 15.6% over the last year enhances its liquidity and shows there is steady demand for its products Software is difficult to replicate at scale and leads to a best-in-class gross margin of 87.8% VRSN is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders VeriSign is trading at $281.64 per share, or 16.3x forward price-to-sales. Is now the right time to buy? See for yourself in our full research report, it's free. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
2 Bank Stocks for Long-Term Investors and 1 to Brush Off
Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. But concerns about loan losses and tightening regulations have tempered enthusiasm, and over the past six months, the banking industry has pulled back by 6.9%. This drop was discouraging since the S&P 500 held its ground. Only some companies are subject to these dynamics, however, and a handful of high-quality businesses can deliver earnings growth in any environment. Keeping that in mind, here are two bank stocks boasting durable advantages and one we're swiping left on. Market Cap: $3.38 billion Starting as a small community bank in 1950 and expanding through strategic acquisitions across the Southeast, United Community Banks (NYSE:UCB) is a regional bank holding company that provides financial services including loans, deposits, wealth management, and merchant services across the southeastern United States. Why Are We Hesitant About UCB? Sales trends were unexciting over the last two years as its 1.8% annual growth was below the typical bank company Net interest margin of 3.3% reflects its high servicing and capital costs Annual earnings per share growth of 1.1% underperformed its revenue over the last five years, showing its incremental sales were less profitable At $27.85 per share, United Community Banks trades at 0.9x forward P/B. Dive into our free research report to see why there are better opportunities than UCB. Market Cap: $8.01 billion Tracing its roots back to 1868 when it was founded during Texas's post-Civil War reconstruction era, Cullen/Frost Bankers (NYSE:CFR) operates Frost Bank, a Texas-based financial institution providing commercial and consumer banking, wealth management, and insurance services. Why Is CFR Interesting? Impressive 13.8% annual net interest income growth over the last four years indicates it's winning market share this cycle Net interest margin jumped by 55.3 basis points (100 basis points = 1 percentage point) over the last two years, giving the company more resources to pursue growth initiatives Annual tangible book value per share growth of 22.1% over the last two years was superb and indicates its capital strength increased during this cycle Frost Bank's stock price of $124.56 implies a valuation ratio of 1.9x forward P/B. Is now the time to initiate a position? Find out in our full research report, it's free. Market Cap: $5.10 billion Founded in 1903 and rebranded from Bank of the Ozarks in 2018, Bank OZK (NASDAQ:OZK) is a commercial bank that specializes in real estate lending while offering a full range of banking services to individuals and businesses. Why Are We Positive On OZK? Impressive 13.8% annual net interest income growth over the last four years indicates it's winning market share this cycle Earnings growth has trumped its peers over the last two years as its EPS has compounded at 11.2% annually Balance sheet strength has increased this cycle as its 10.1% annual tangible book value per share growth over the last five years was exceptional Bank OZK is trading at $45.03 per share, or 0.9x forward P/B. Is now a good time to buy? See for yourself in our full research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
